Computational discovery of plant-based inhibitors against human carbonic anhydrase IX and molecular dynamics simulation
- 24 May 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Biomolecular Structure and Dynamics
- Vol. 39 (8), 2754-2770
- https://doi.org/10.1080/07391102.2020.1753579
Abstract
Carbonic anhydrase IX (hCAIX) is a membrane-spanning metalloenzyme, encoded by CA9 gene, which can lead to various carcinomas if upregulated. Due to its overexpression in many cancer tissues, hCAIX has become a promising target for developing anticancer therapeutics. Furthermore, several classes of small-molecules have shown to inhibit the hCAIX expression. In this study, therefore, we screened (n = 42) plant-derived compounds to identify the most potent hCAIX inhibitors and to understand their interactions with hCAIX and drug candidacy through in silico approaches. Among all, only three compounds (i.e. fraxoside, scopolin, and xanthone,) provided higher binding affinity toward hCAIX protein as compared to the native ligand. In standard docking, scopolin showed -4.97 kcal/mol of binding energy with hCAIX while control ligand provided -4.45 kcal/mol. In precise docking, the highest binding affinity was found for fraxoside (-7.67 kcal/mol) as compared to -3.04 kcal/mol of the control. The Gibbs free energy (Delta G) of these potent leads was also consistent and in support of the docking studies. The binding interactions were also found to be stable in dynamics simulation. Furthermore, analysis of protein-protein interactions and co-expression revealed the possible association of CA9 gene with other tumorous genes, especially angiogenesis factor HIF1A which will most likely be affected by the identified inhibitors. With further experimental validation, therefore, these potential inhibitors could be effective against hCAIX protein, thereby, paving the way for prospective anticancer therapeutics. Communicated by Ramaswamy H. SarmaThis publication has 97 references indexed in Scilit:
- Gold nanoparticles as novel agents for cancer therapyThe British Journal of Radiology, 2012
- Hypoxia-Induced Angiogenesis: Good and EvilGenes & Cancer, 2011
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics SimulationsJournal of Chemical Information and Modeling, 2010
- Prediction of Potency of Protease Inhibitors Using Free Energy Simulations with Polarizable Quantum Mechanics-Based Ligand Charges and a Hybrid Water ModelJournal of Chemical Information and Modeling, 2009
- Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IXProceedings of the National Academy of Sciences of the United States of America, 2009
- UniHI 4: new tools for query, analysis and visualization of the human protein–protein interactomeNucleic Acids Research, 2008
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profilingBritish Journal of Pharmacology, 2007
- The role of carbonic anhydrase IX overexpression in kidney cancerEuropean Journal of Cancer, 2005
- Making optimal use of empirical energy functions: Force‐field parameterization in crystal spaceProteins, 2004